Filana Therapeutics, Inc. (FLNA)
0.9504
+0.02
(+2.19%)
USD |
NASDAQ |
Aug 25, 13:43
Filana Therapeutics Total Assets (Quarterly) : 103.90M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 103.90M |
| March 31, 2026 | 108.37M |
| December 31, 2025 | 118.36M |
| September 30, 2025 | 129.73M |
| June 30, 2025 | 135.38M |
| March 31, 2025 | 140.93M |
| December 31, 2024 | 157.53M |
| September 30, 2024 | 223.75M |
| June 30, 2024 | 243.57M |
| March 31, 2024 | 155.72M |
| December 31, 2023 | 151.66M |
| September 30, 2023 | 172.53M |
| June 30, 2023 | 197.25M |
| March 31, 2023 | 218.11M |
| December 31, 2022 | 234.83M |
| September 30, 2022 | 207.29M |
| June 30, 2022 | 227.38M |
| March 31, 2022 | 244.19M |
| December 31, 2021 | 266.78M |
| September 30, 2021 | 274.25M |
| June 30, 2021 | 281.30M |
| March 31, 2021 | 284.05M |
| December 31, 2020 | 94.30M |
| September 30, 2020 | 25.40M |
| June 30, 2020 | 25.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.98M |
| December 31, 2019 | 23.49M |
| September 30, 2019 | 18.38M |
| June 30, 2019 | 18.80M |
| March 31, 2019 | 19.52M |
| December 31, 2018 | 20.14M |
| September 30, 2018 | 20.84M |
| June 30, 2018 | 9.833M |
| March 31, 2018 | 11.06M |
| December 31, 2017 | 10.83M |
| September 30, 2017 | 12.38M |
| June 30, 2017 | 14.27M |
| March 31, 2017 | 17.60M |
| December 31, 2016 | 19.30M |
| September 30, 2016 | 22.48M |
| June 30, 2016 | 24.94M |
| March 31, 2016 | 28.63M |
| December 31, 2015 | 31.92M |
| September 30, 2015 | 35.65M |
| June 30, 2015 | 37.76M |
| March 31, 2015 | 39.64M |
| December 31, 2014 | 40.91M |
| September 30, 2014 | 43.59M |
| June 30, 2014 | 45.39M |
| March 31, 2014 | 47.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CorMedix, Inc. | 904.05M |
| Eloxx Pharmaceuticals, Inc. | 63.39M |
| Cannabis Global, Inc. | 0.885M |
| Breakthrough Chemistry, Inc. | 1.300M |
| BioStem Technologies, Inc. | 48.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 40.29M |
| Shareholders Equity (Quarterly) | 63.61M |
| Current Ratio | 2.085 |